Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERADICATE Hp: RHB-105 in H. pylori infection
NCT01980095Phase 3Completed
- Sponsor
- RedHill Biopharma
- Start
- Nov 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omeprazole + amoxicillin + rifabutin in Helicobacter pylori infection, sponsored by RedHill Biopharma. Started Nov 2013; status: completed.
02
Drugs
omeprazole + amoxicillin + rifabutin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01980095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01980095.